Disruptive Materials will give rejected drugs a second chance.

Uppsala University is spinning out Disruptive Materials, which will commercialise the new material Upsalite.

A large proportion of all drug candidates, some 80%, are rejected during research and development because they are not soluble. Low solubility is a problem, because it limits the body’s ability to absorb the drug.

Upsalite could potentially lead to pharmaceutical companies reconsidering a large amount of discarded drug candidates. The material is an alkaline earth metal carbonate. Alkaline earth metals are beryllium, magnesium, calcium, strontium,…